Centers for Medicare and Medicaid Joins with FDA in New Initiative to Improve Patient Safety (Senior Journal)
May 22, 2008 - The Centers for Medicare & Medicaid Services (CMS) will begin sharing data on prescription drug use to help government agencies and academic researchers improve the safety, quality and efficiency of health care services, while as part of this new initiative launched by Health and Human Services, the Food and Drug Administration will be more proactive in its surveillance of medical ...

Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis (PR Newswire via Yahoo! Finance)
Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S. Food and Drug Administration issued an approvable letter on May 21 for bazedoxifene, a selective estrogen receptor modulator, for the treatment of postmenopausal osteoporosis.

US FDA bars Scientific Labs production (PharmaBiz)
The US Food and Drug Administration (FDA) has announced that Scientific Laboratories Inc., and its president, Rajeshwari Patel, and chief executive officer, Amit Roy, have signed a Consent Decree of Permanent Injunction and are barred from manufacturing and distributing drug products until they bring their manufacturing operations into compliance with law and obtain approval for their products.